Your browser doesn't support javascript.
loading
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab.
Kristeleit, Rebecca; Mathews, Cara; Redondo, Andres; Boklage, Susan; Hanlon, Jennifer; Im, Ellie; Brown, Jubilee.
Afiliación
  • Kristeleit R; Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK rebecca.kristeleit@gstt.nhs.uk.
  • Mathews C; Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA.
  • Redondo A; Department of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
  • Boklage S; GSK, Philadelphia, Pennsylvania, USA.
  • Hanlon J; GSK, Philadelphia, Pennsylvania, USA.
  • Im E; GSK, Waltham, Massachusetts, USA.
  • Brown J; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Int J Gynecol Cancer ; 2022 Aug 16.
Article en En | MEDLINE | ID: mdl-35973737
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article